High Costs, Low Margins, and Regulatory Hurdles Hinder Pharma’s Adoption of Advanced Manufacturing Technologies

Benchmark Banner Ad

 

The ongoing drug shortage crisis in the U.S. underscores a critical need for innovation in pharmaceutical manufacturing. As manufacturing issues, outdated technologies, and geopolitical risks contribute to shortages that impact patient care and elevate healthcare costs, the introduction of Advanced Manufacturing Technologies (AMTs) offers a beacon of hope. AMT technologies promise to enhance quality control and reduce production downtime, yet their adoption in generic drug production remains low despite obvious benefits.

Why is the pharmaceutical industry slow to adopt technologies that could revolutionize drug availability and cost?

Mike Tracy, a C-Level Healthcare Operations Strategist, dives into the complexities of integrating Advanced Manufacturing Technologies in drug production. Mike points out that while AMTs can drastically reduce bottlenecks in drug production, the significant initial investment and stringent regulatory landscape pose substantial hurdles.

“Every AMT has a high startup cost and generic drugs have very razor-thin margins to begin with. We’re not talking about a new drug that’s not already out in the market where you’re going to have a high margin and it makes sense to invest millions,” Tracy explains.

Article written by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

AI data center
Power, Cooling, and Risk: What It Takes to Bring a 100MW AI Data Center Online
March 28, 2026

The industry knows how to build data centers. What it’s still figuring out is how to turn on AI factories at scale. With facilities now crossing 100 megawatts—far beyond the 5 to 10 megawatt norm of traditional builds—operators are no longer just validating equipment. They’re testing whether entire systems—power, cooling, controls, and the teams behind…

Read More
beauty
Building Beauty for Real Women: Why Brands Must Focus on Longevity, Not Hype
March 25, 2026

Walk into any beauty aisle—or scroll through your feed for five minutes—and it’s clear the industry is obsessed with what’s new. New formulas, new trends, new “rules.” But for many women, especially those who’ve been using makeup for decades, the question isn’t what’s new—it’s what actually works. And increasingly, the answer isn’t coming from the…

Read More
Physician
Fixing the Physician Experience: Why Advocacy Is Healthcare’s Next Frontier
March 25, 2026

Physician burnout has become a defining challenge in healthcare, with research showing that a substantial portion of clinicians—anywhere from roughly a quarter to over half—experience emotional exhaustion, driven more by systemic pressures like administrative burden and reduced autonomy than by individual resilience alone. As healthcare systems face growing staffing shortages and rising patient demand, the…

Read More
career
From Starting Over In A New Country To Reaching The C-Suite: A CFO’s Career Comeback
March 25, 2026

Global mobility is reshaping the modern workforce, with millions of professionals relocating each year in pursuit of opportunity, stability, or growth. Yet behind the headlines of talent migration lies a quieter, more difficult truth: restarting a career from scratch—even after years of success—is far more common than people expect. In fact, many skilled immigrants…

Read More